|
ZNF555 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.210480E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.176300E-04 |
| Normal-vs-Stage2 |
2.833400E-04 |
| Normal-vs-Stage3 |
4.185200E-04 |
| Normal-vs-Stage4 |
4.007900E-04 |
| Stage1-vs-Stage2 |
4.349000E-01 |
| Stage1-vs-Stage3 |
3.125200E-01 |
| Stage1-vs-Stage4 |
1.011570E-01 |
| Stage2-vs-Stage3 |
7.076000E-01 |
| Stage2-vs-Stage4 |
3.423800E-01 |
| Stage3-vs-Stage4 |
7.067600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.023400E-04 |
| Normal-vs-AfricanAmerican |
4.829100E-04 |
| Normal-vs-Asian |
5.598400E-03 |
| Caucasian-vs-AfricanAmerican |
9.722800E-01 |
| Caucasian-vs-Asian |
4.849400E-01 |
| AfricanAmerican-vs-Asian |
4.587800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.67389999995127E-07 |
| Normal-vs-Female |
3.991600E-02 |
| Male-vs-Female |
7.036200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.361800E-03 |
| Normal-vs-Extreme_Weight |
3.88890000000419E-05 |
| Normal-vs-Obese |
4.985500E-04 |
| Normal-vs-Extreme_Obese |
1.675910E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.916600E-01 |
| Normal_Weight-vs-Obese |
7.292600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.435000E-01 |
| Extreme_Weight-vs-Obese |
2.094200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.452000E-01 |
| Obese-vs-Extreme_Obese |
7.533800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.267580E-02 |
| Normal-vs-Age(41-60Yrs) |
3.378100E-03 |
| Normal-vs-Age(61-80Yrs) |
8.6616999994682E-07 |
| Normal-vs-Age(81-100Yrs) |
5.56760000000045E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.087800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.470200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.494000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.938240E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.049700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.370780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.83959999999961E-05 |
| Normal-VS-Type2 PRCC |
7.99379999971706E-07 |
| Normal-VS-KIRP CIMP |
2.123800E-03 |
| Normal-VS-Unclassified PRCC |
3.299600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.882100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.671600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.240200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.308000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.075840E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.768200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97600000029219E-07 |
| Normal-vs-N1 |
2.941700E-03 |
| Normal-vs-N2 |
6.172600E-04 |
| N0-vs-N1 |
2.027000E-01 |
| N0-vs-N2 |
1.101010E-01 |
| N1-vs-N2 |
7.002000E-02 |
|
|
